Diffusion-weighted MRI of the prostate;Diffusionsgewichtete MRT der Prostata

Radiologe

Volumn 51, Issue 3, 2011, Pages 205-214

  Mueller Lisse, U G ^a   Mueller Lisse, U L ^a   Zamecnik, P ^b   Schlemmer, H P W ^b   Scherr, M K ^a  

^a LUDWIG MAXIMILIANS UNIVERSITY   (Germany)

^b GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

Author keywords

Diffusion; Diffusion weighted imaging (DWI); Magnetic resonance imaging (MRI); Prostate; Prostate cancer

Indexed keywords

PROSTATE SPECIFIC ANTIGEN; TUMOR MARKER;

BIOPSY; BLOOD; CELL COUNT; COMPARATIVE STUDY; DIFFUSION WEIGHTED IMAGING; EQUIPMENT DESIGN; HUMAN; IMAGE PROCESSING; INSTRUMENTATION; MALE; METHODOLOGY; NUCLEAR MAGNETIC RESONANCE IMAGING; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PATHOLOGY; PROSTATE; PROSTATE TUMOR; PROSTATITIS; REVIEW; SENSITIVITY AND SPECIFICITY;

BIOPSY; CELL COUNT; DIFFUSION MAGNETIC RESONANCE IMAGING; EQUIPMENT DESIGN; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MAGNETIC RESONANCE SPECTROSCOPY; MALE; PROSTATE; PROSTATE-SPECIFIC ANTIGEN; PROSTATIC NEOPLASMS; PROSTATITIS; SENSITIVITY AND SPECIFICITY; TUMOR MARKERS, BIOLOGICAL;

EID: 79954588903     PISSN: 0033832X     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00117-010-2061-2     Document Type: Article

References (30)

1. American Joint Committee on Cancer (AJCC) (2002) Cancer staging manual. 6. Aufl. Springer, Berlin Heidelberg New York
2. Gesundheitsberichterstattung des Bundes, Robert Koch-Institut in Zusammenarbeit mit dem Statistischen Bundesamt (2007) Prostataerkrankungen. Heft 36, Robert Koch-Institut, Berlin ISBN 978-3-89606-177-5, ISSN 1437-5478
3. Groenendaal G, van den Berg CAT, Korporaal JG et al (2010) Simultaneous MRI diffusion and perfusion imaging for tumor delineation in prostate cancer patients. Radiother Oncol 95:185-190
4. Gürses B, Tasdelen N, Yencilek F et al (2010) Diagnostic utility of DTI in prostate cancer. Eur J Radiol doi:10.1016/j.ejrad.2010.01.009
5. Heuck A, Scheidler J, Sommer B et al (2003) MR-Tomographie des Prostatakarzinoms. Radiologe 43:464-473 (Pubitemid 36841593)
6. Katahira K, Takahara T, Kwee TC et al (2010) Ultra-high-b-value diffusion-weighted MR imaging for the detection of prostate cancer: evaluation in 201 cases with histopathological correlation. Eur Radiol. DOI 10.1007/s00330-010-1883-7; published online 18-July-2010
7. Kim CK, Park BK, Kim B (2010) High-b-value diffusion-weighted imaging at 3 T to detect prostate cancer: comparisons between b values of 1,000 and 2,000 s/mm2. AJR 194:W33-W37. DOI 10.2214/AJR.09.3004
8. Kozlowski P, Chang SD, Mengd R et al (2010) Combined prostate diffusion tensor imaging and dynamic contrast enhanced MRI at 3T - quantitative correlation with biopsy. Magn Reson Imaging 28:621-628
9. Kurhanewicz J, Vigneron DB, Hricak H et al (1996) Three-dimensional H-1 MR spectroscopic imaging of the in situ human prostate with high (0.24-0.7-cm3) spatial resolution. Radiology 198:795-805 (Pubitemid 26066301)
10. Langer DL, van der Kwast TH, Evans AJ et al (2008) Intermixed normal tissue within prostate cancer: effect on MR imaging measurements of apparent diffusion coefficient and T2-sparse versus dense cancers. Radiology 249:900-908
11. Langer DL, van der Kwast TH, Evans AJ et al (2010) Prostate tissue composition and MR measurements: investigating the relationships between ADC, T2, ktrans, ve, and corresponding histologic features. Radiology 255:485-494
12. Müller-Lisse UL, Hofstetter A (2003) Urologische Diagnostik des Prostatakarzinoms. Radiologe 43:432-440 (Pubitemid 36841589)
13. Mueller-Lisse UG, Miller K (2010) Bildgebende Verfahren bei Primärdiagnose und Staging des Prostatakarzinoms. Urologe A-49:190-198
14. Mueller-Lisse UG, Scherr M (2003) 1H-MR-Spektroskopie der Prostata: Ein Überblick. Radiologe 43:481-488
15. Mueller-Lisse UG, Scherr MK (2009) Klinische Magnetresonanzuntersuchungen der Prostata. In: Roth SL, Albers P, Budach W (Hrsg) Klinische Onkologie 2009/2010, Bd 4: Uroonkologie. dup, Düsseldorf University Press, ISBN 978-3-940671-18-9, S 38-46
16. Mueller-Lisse UG, Scherr MK, Mueller-Lisse UL (2008) Male pelvis: prostate. In: Reiser MF, Semmler W, Hricak H (eds) Magnetic resonance tomography, 4. Aufl. Springer, Berlin Heidelberg New York, pp 1018-1039
17. Mueller-Lisse UG, Swanson MG, Vigneron DB et al (2001) Time-dependent effects of hormone-deprivation therapy on prostate metabolism as detected by combined magnetic resonance imaging and 3D magnetic resonance spectroscopic imaging. Magn Reson Med 46:49-57 (Pubitemid 32592138)
18. Oto A, Kayhan A, Jiang Y et al (2010) Prostate cancer: differentiation of central gland cancer from benign prostatic hyperplasia by using diffusion-weighted and dynamic contrast-enhanced MR imaging. Radiology. DOI 10.1148/radiol.10100021/-/DC1
19. Portalez D, Rollin G, Leandri P et al (2010) Prospective comparison of T2w-MRI and dynamic-contrast-enhanced MRI, 3D-MR spectroscopic imaging or diffusion-weighted MRI in repeat TRUS-guided biopsies. Eur Radiol. DOI 10.1007/s00330-010-1868-6
20. Reinsberg SA, Payne GS, Riches SF et al (2007) Combined use of diffusion weighted MRI and 1H MR spectroscopy to increase accuracy in prostate cancer detection. AJR Am J Roentgenol 188:91-98 (Pubitemid 46012494)
21. Reischauer C, Wilm BJ, Froehlich JM et al (2010) High-resolution diffusion tensor imaging of prostate cancer using a reduced FOV technique. Eur J Radiol. DOI 10.1016/j.ejrad.2010.06.038
22. Rosenkrantz AB, Kopec M, Kong X et al (2010) Prostate cancer vs. post-biopsy hemorrhage: diagnosis with T2- and diffusion-weighted imaging. J Magn Reson Imaging 31:1387-1394
23. Seitz M, Scher B, Scherr M et al (2007) Bildgebende Verfahren bei der Diagnose des Prostatakarzinoms. Urologe A-46:W1435-1446
24. Song I, Kim CK, Park BK, Park W (2010) Assessment of response to radiotherapy for prostate cancer: value of diffusion-weighted MRI at 3 T. AJR 194:W477-W482. DOI 10.2214/AJR.09.3557
25. S3-Leitlinie Prostatakarzinom: .,Interdisziplinäre Leitlinie der Qualität S3 zur Früherkennung, Diagnose und Therapie der verschiedenen Stadien des Prostatakarzinoms" unter: http://www.leitlinien.net/ (Stand: 22.12.2009)
26. Tan CH, Wang J, Kundra V (2010) Diffusion weighted imaging in prostate cancer. Eur Radiol. DOI 10.1007/s00330-010-1960-y; published online 09-October-2010
27. Wittekind C, Mezer HJ, Bootz F (Hrsg) (2002) UICC - International Union Against Cancer: TNM-Klassifikation maligner Tumoren. 6. Aufl. Springer, Heidelberg Berlin New York, pp 295
28. Woodfield CA, Tung GA, Grand DJ et al (2010) Diffusion-weighted MRI of peripheral zone prostate cancer: comparison of tumor apparent diffusion coefficient with Gleason score and percentage of tumor on core biopsy. AJR 194:W316-W322. DOI 10.2214/AJR.09.2651
29. Xu J, Humphrey PA, Kibel AS et al (2009) Magnetic resonance diffusion characteristics of histologically defined prostate cancer in humans. Magn Reson Med 61:842-850
30. Yagǐ AB, Özari N, Aybek Z, Düzcan E (2010) The value of diffusion-weighted MRI for prostate cancer detection and localization. Diagn Interv Radiol. DOI 10.4261/1305-3825. DIR.3399-10.1; published online 6-August-2010